Moneycontrol PRO
you are here: HomeNewsIndia

Over 61 crore COVID-19 vaccine doses administered in India: Govt

"India achieves unprecedented milestone! 50 per cent of the eligible population inoculated with the first dose of COVID-19 vaccine. Keep it up India. Let us fight Corona," Union Health Minister Mansukh Mandaviya tweeted.

August 27, 2021 / 09:00 AM IST
Representative image

Representative image

India’s COVID-19 vaccination coverage has crossed 61 crore, the Union health ministry said.

Nearly 68 lakh (67,87,305) vaccine doses were administered on Thursday, according to the 7 pm provisional report.

Final reports would be completed for the day by late night, the ministry said.

"India achieves unprecedented milestone! 50 per cent of the eligible population inoculated with the first dose of COVID-19 vaccine. Keep it up India. Let us fight Corona," Union Health Minister Mansukh Mandaviya tweeted.

Cumulatively, 23,18,95,731 individuals in the age group of 18-44 years have received their first dose and 2,33,74,357 their second dose since the start of phase-3 of the vaccination drive, according to health ministry data.

Close

COVID-19 Vaccine

Frequently Asked Questions

View more
How does a vaccine work?

A vaccine works by mimicking a natural infection. A vaccine not only induces immune response to protect people from any future COVID-19 infection, but also helps quickly build herd immunity to put an end to the pandemic. Herd immunity occurs when a sufficient percentage of a population becomes immune to a disease, making the spread of disease from person to person unlikely. The good news is that SARS-CoV-2 virus has been fairly stable, which increases the viability of a vaccine.

How many types of vaccines are there?

There are broadly four types of vaccine — one, a vaccine based on the whole virus (this could be either inactivated, or an attenuated [weakened] virus vaccine); two, a non-replicating viral vector vaccine that uses a benign virus as vector that carries the antigen of SARS-CoV; three, nucleic-acid vaccines that have genetic material like DNA and RNA of antigens like spike protein given to a person, helping human cells decode genetic material and produce the vaccine; and four, protein subunit vaccine wherein the recombinant proteins of SARS-COV-2 along with an adjuvant (booster) is given as a vaccine.

What does it take to develop a vaccine of this kind?

Vaccine development is a long, complex process. Unlike drugs that are given to people with a diseased, vaccines are given to healthy people and also vulnerable sections such as children, pregnant women and the elderly. So rigorous tests are compulsory. History says that the fastest time it took to develop a vaccine is five years, but it usually takes double or sometimes triple that time.

View more
Show

As on Day-223 of the vaccination drive (August 26), 46,88,114 were vaccinated for the first dose and 20,99,191 received the second dose, according to the provisional report till 7 PM, the data stated.

The vaccination exercise as a tool to protect the most vulnerable population groups in the country from COVID-19 continues to be regularly reviewed and monitored at the highest level, the ministry said.

The countrywide vaccination drive was rolled out on January 16 with healthcare workers (HCWs) getting inoculated in the first phase. The vaccination of frontline workers (FLWs) started from February 2.

The next phase of COVID-19 vaccination commenced from March 1 for people over 60 years of age and those aged 45 and above with specified co-morbid conditions.

The country launched vaccination for all people aged more than 45 years from April 1.

The government then decided to expand its vaccination drive by allowing everyone above 18 to be vaccinated from May 1.

(With PTI inputs)
Moneycontrol News
first published: Aug 27, 2021 09:00 am
Sections
ISO 27001 - BSI Assurance Mark